Supreme Pharmaceuticals Announces Debt Settlement for Shares

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 30, 2015) - Supreme Pharmaceuticals Inc. (the "Company") (OTC PINK:SPRWF)(CSE:SL) advises that it has settled outstanding debts by the issuance of 500,000 shares at a deemed price of $0.3375 per share. These shares shall be subject to a 4 month trading restriction.